Domainex

Domainex company information, Employees & Contact Information

Explore related pages

Related company profiles:

Domainex is a fully integrated drug discovery service company based near Cambridge, UK serving pharmaceutical, biotechnology, academic and patient foundations globally. Our expertise and commitment to providing high quality services has resulted in a strong success record in drug discovery, delivering an average one candidate drug every year for the past six years. Domainex’s highly experienced molecular, protein, structural and assay biologists plus medicinal, computational and analytical chemists can be leveraged through our CRO services. Domainex’s focus is on providing highly efficient and well considered scientific solutions to enable successful drug discovery programmes against a wide range of drug targets. Domainex offers a range of services including: • Medicinal chemistry (including SBDD) • FragmentBuilder (Domainex’s proprietary fragment screening platform) • Computational Chemistry (including LeadBuilder Domainex’s proprietary virtual screening platform) • Assay Development and Screening (biochemical, biophysical and cell assays) • iPSC and immune cell biology • Protein Production • CDH (Domainex’s proprietary technology which enables the rapid identification of stable, soluble protein domains) • Analytical chemistry • X-ray crystallography services Whether your project is at an early stage of drug discovery or has already identified chemical matter, our processes have been shown to result in a 30% time-saving compared to industry standards and use less resource, allowing prudent management of your own budget.
Looking for a particular Domainex employee's phone or email?

Domainex Questions

News

Qualified attorney is new Domainex CEO - Business Weekly

Qualified attorney is new Domainex CEO Business Weekly

Domainex welcomes new CEO as it plots growth - Cambridge Independent

Domainex welcomes new CEO as it plots growth Cambridge Independent

Drug discovery CRO Domainex opens facility in UK - drugdiscoverytrends.com

Drug discovery CRO Domainex opens facility in UK drugdiscoverytrends.com

Using spectral shift in drug discovery projects - News-Medical

Using spectral shift in drug discovery projects News-Medical

Domainex secures funding from Takeda Research Investment | UCL News - UCL - University College London

Domainex secures funding from Takeda Research Investment | UCL News - UCL University College London

British contract research firms fight to find science talent - Chemical & Engineering News

British contract research firms fight to find science talent Chemical & Engineering News

Domainex and its new Cambridge facility fit for a King - Business Weekly

Domainex and its new Cambridge facility fit for a King Business Weekly

Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells - ACS Publications

Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells ACS Publications

UK and Australia increase business ties at AusBiotech - GOV.UK

UK and Australia increase business ties at AusBiotech GOV.UK

Domainex’s Biology Centre of Excellence opening combines with King’s Award presentation - Cambridge Independent

Domainex’s Biology Centre of Excellence opening combines with King’s Award presentation Cambridge Independent

Cambridge quartet make changes at the top - Business Weekly

Cambridge quartet make changes at the top Business Weekly

Top Domainex Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant